Press Releases from Hyperphosphatemia Therapeutics-Pharma Proff (1 total)
Hyperphosphatemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Resul …
Hyperphosphatemia is a medical condition which involves increased level of serum phosphate concentration in the blood. Phosphate is required for bone and cell formation, genetic coding and energy metabolism. An individual is said to have hyperphosphatemia, if the phosphate concentration increasing beyond > 4.5 mg/dL (> 1.46 mmol/L). Similar to calcium, vitamin D is required to properly absorb phosphate.
Download the sample report @ https://www.pharmaproff.com/request-sample/1138
The various causes of hyperphosphatemia…
